Davis T - Search Results

1

Cloud-based Predictive Modeling System and its Application to Asthma Readmission Prediction.

Chen R, Su H, Khalilia M, Lin S, Peng Y, Davis T, Hirsh DA, Searles E, Tejedor-Sojo J, Thompson M, Sun J. Chen R, et al. Among authors: davis t. AMIA Annu Symp Proc. 2015 Nov 5;2015:406-15. eCollection 2015. AMIA Annu Symp Proc. 2015. PMID: 26958172 Free PMC article.

2

High performance liquid chromatography of a new anticancer drug, ADCA--physicochemical properties and pharmacokinetics.

Peng YM, Davis TP, Alberts DS. Peng YM, et al. Among authors: davis tp. Life Sci. 1981 Jul 27;29(4):361-9. doi: 10.1016/0024-3205(81)90329-5. Life Sci. 1981. PMID: 7278493 No abstract available.

3

In vivo and in vitro metabolism of the new anticancer drug bisantrene.

Peng YM, Alberts DS, Davis TP. Peng YM, et al. Among authors: davis tp. Cancer Chemother Pharmacol. 1985;14(1):15-20. doi: 10.1007/BF00552718. Cancer Chemother Pharmacol. 1985. PMID: 3965156

4

HPLC, MS, and pharmacokinetics of melphalan, bisantrene and 13-cis retinoic acid.

Davis TP, Peng YM, Goodman GE, Alberts DS. Davis TP, et al. J Chromatogr Sci. 1982 Nov;20(11):511-6. doi: 10.1093/chromsci/20.11.511. J Chromatogr Sci. 1982. PMID: 6960001

5

A method for the simultaneous measurement of the new anthracycline derivative 4'-deoxydoxorubicin and its metabolites by reversed phase liquid chromatography.

Peng YM, Alberts DS, Salmon SE, Davis TP. Peng YM, et al. Among authors: davis tp. Invest New Drugs. 1984;2(3):277-80. doi: 10.1007/BF00175377. Invest New Drugs. 1984. PMID: 6511234

6

High-performance liquid chromatography of the provitamin A beta-carotene in plasma.

Peng YM, Beaudry J, Alberts DS, Davis TP. Peng YM, et al. Among authors: davis tp. J Chromatogr. 1983 Apr 8;273(2):410-4. doi: 10.1016/s0378-4347(00)80962-7. J Chromatogr. 1983. PMID: 6863453 No abstract available.

7

Disposition of mitoxantrone in patients.

Alberts DS, Peng YM, Leigh S, Davis TP, Woodward DL. Alberts DS, et al. Among authors: davis tp. Cancer Treat Rev. 1983 Dec;10 Suppl B:23-7. doi: 10.1016/0305-7372(83)90018-x. Cancer Treat Rev. 1983. PMID: 6661732 No abstract available.

8

Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone.

Peng YM, Ormberg D, Alberts DS, Davis TP. Peng YM, et al. Among authors: davis tp. J Chromatogr. 1982 Dec 10;233:235-47. doi: 10.1016/s0378-4347(00)81750-8. J Chromatogr. 1982. PMID: 7161336

9

Disposition of mitoxantrone in cancer patients.

Alberts DS, Peng YM, Leigh S, Davis TP, Woodward DL. Alberts DS, et al. Among authors: davis tp. Cancer Res. 1985 Apr;45(4):1879-84. Cancer Res. 1985. PMID: 3978648

10

The role of serum and tissue pharmacology studies in the design and interpretation of chemoprevention trials.

Plezia PM, Alberts DS, Peng YM, Xu MJ, Sayers S, Davis TP, Surwit EA, Meyskens FL Jr. Plezia PM, et al. Among authors: davis tp. Prev Med. 1989 Sep;18(5):680-7. doi: 10.1016/0091-7435(89)90039-x. Prev Med. 1989. PMID: 2694162 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,562 results

Search Page

Filters